CLINICAL_TRIALS
trial_result
· 2019-03-04
Clinical Trial Update: Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Phase 2]
Summary
Phase 2 trial evaluating Arimidex with or without Faslodex in postmenopausal women with HR-positive breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mothaffar Rimawi | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-03-04